Authors:
SEGAL P
FEIG PU
SCHERNTHANER G
RATZMANN KP
RYBKA J
PETZINNA D
BERLIN C
Citation: P. Segal et al., THE EFFICACY AND SAFETY OF MIGLITOL THERAPY COMPARED WITH GLIBENCLAMIDE IN PATIENTS WITH NIDDM INADEQUATELY CONTROLLED BY DIET ALONE, Diabetes care, 20(5), 1997, pp. 687-691
Authors:
SCHERNTHANER G
FEIG P
HANEFELD M
PETZINNA D
RAPTIS S
RYBKA J
STANDL E
Citation: G. Schernthaner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM PATIENTS NOT RESPONDINGSUFFICIENTLY TO SULFONYLUREA, Diabetes, 45, 1996, pp. 445-445
Authors:
SCHERNTAHNER G
FEIG P
HANEFELD M
PETZINNA D
RAPTIS S
RYBKA J
STANDL E
Citation: G. Scherntahner et al., COMPARISON OF MIGLITOL AND METFORMIN IN NIDDM NOT SUFFICIENTLY RESPONDING TO SULFONYLUREAS, Diabetes, 45, 1996, pp. 746-746
Citation: A. Szczepaniak et al., MEMBRANE ASSOCIATION OF THE RIESKE IRON-SULFUR PROTEIN, Zeitschrift fur Naturforschung. C, A journal of biosciences, 50(7-8), 1995, pp. 535-542
Authors:
RATZMANN KP
FEIG PU
PETZINNA D
RYBKA J
SCHERNTHANER G
SEGAL P
Citation: Kp. Ratzmann et al., TREATMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS - MIGLITOL VERSUS GLIBENCLAMIDE VERSUS PLACEBO, Diabetologia, 38, 1995, pp. 199-199
Authors:
KOEV D
ZLATEVA S
SUSIC M
BABIC D
PROFOZIC V
SKRABALO Z
LANGROVA H
CVRKALOVA AL
RAJECOVA E
KLIMES I
SEBOKOVA E
HANZEN E
LACKO A
KREZE A
RYBKA J
GUS M
KALITS I
KARADI I
ROMICS L
LEOWSKI J
ORLANDINI L
Citation: D. Koev et al., IMPROVEMENT OF LIPOPROTEIN LIPID-COMPOSITION IN TYPE-II DIABETIC-PATIENTS WITH CONCOMITANT HYPERLIPOPROTEINEMIA BY ACIPIMOX TREATMENT - RESULTS OF A MULTICENTER TRIAL, Diabetes care, 16(9), 1993, pp. 1285-1290
Citation: J. Rybka, NEUROPSYCHOLOGY, NEUROPSYCHIATRY AND BEHA VIORAL NEUROLOGY - ENGLISH - JOSEPH,R, Ceskoslovenska psychologie, 37(3), 1993, pp. 273-274